Factors associated with the alteration of baseline glycemia in the first posthospitalization checkup in patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.24265/horizmed.2018.v18n2.06Keywords:
Diabetes mellitus, Blood glucose, HospitalizationAbstract
Objective: To analyze the factors associated with the alteration of baseline glycemia in the first post-hospitalization checkup in patients with type 2 diabetes mellitus (T2DM). Materials and methods: A retrospective observational case-control study was performed in a 1:1 ratio. One hundred (100) medical records of patients of both genders and over 18 years of age with T2DM who had a medical checkup within the first 3 months after hospitalization were analyzed. Cases were defined as those with high baseline glycemia (> 130 mg/dL) and controls were defined as those who had normal glycemic levels (≤ 130 mg/dL). Mean and percentages were estimated using the chi-square test and binary logistic regression. Results: Elevated glycemic levels at admission (OR: 2.7, p <0.05), elevated glycemic levels at discharge (OR: 3.7, p <0.005), HbA1c ≥ 9 % during hospitalization (OR: 2.9, p <0.05), high levels of triglycerides (OR: 2.6, p <0.05), and failure to comply with prescribed treatment (OR: 2.15, p <0.005) were associated with high baseline glycemia in the first posthospitalization checkup. Conclusions: High levels of triglycerides and non-compliance with indications are risk factors associated with poor glycemic control at the first outpatient visit after hospitalization.
Downloads
References
Pérez A, Franch J, Cases A, González Juanatey JR, Conthe P, Gimeno E, et al. Relationship between the degree of glycemic control and diabetes characteristics and hyperglycemia treatment in type 2 diabetes. DIABES Study. Med Clin. 2012;138(12):505-11. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22118974
American Diabetes Association. (4) Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization. Diabetes Care. 2015;38(1):20-30. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25537702
Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer M-J, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J. 2007;28(1):88-136. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17220161
International Diabetes Federation. IDF Diabetes Atlas Eight Edition. 2017 [Internet]. Disponible en: http://www.diabetesatlas.org/
Seclen SN, Rosas ME, Arias AJ, Medina CA. Elevated incidence rates of diabetes in Peru: report from PERUDIAB, a national urban population-based longitudinal study. BMJ Open Diabetes Res Care. 2017;5(1):e000401. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28878935
Cook CB, Seifert KM, Hull BP, Hovan MJ, Charles JC, Miller- Cage V, et al. Inpatient to outpatient transfer of diabetes care: planing for an effective hospital discharge. Endocr Pract. 2009;15(3):263-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19364697
Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26(5):1421-6. Disponible en. https://www.ncbi.nlm.nih.gov/pubmed/12716799
Ministerio de Salud del Perú. Principales causas de morbilidad de hospitalización por sexo [Internet], Perú, 2015. Disponible en: http://www.minsa.gob.pe/estadisticas/estadisticas/Morbilidad/HSMacros.asp?00
Moghissi ES, Korytkowski MT, DiNardo M, Einhom D, Hellman R, Hirsh IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care. 2009; 32(6):1119- 1131. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681039/
American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care. 2011; 34(1):11-61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006050/
Jansen S, Buonaiuto V, Márquez-Gómez I, Gómez-Huelgas R. Management of hyperglycemia in the non-critical hospitalized patients with oral feeding. Rev Clin Esp. 2012; 212(2):84-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21798530
Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010; 24(2):84-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19282203
Ramos Marini MR. Actualización en el manejo de la cetoacidosis diabética y el estado hiperosmolar hiperglucémico en adultos. Rev Med Hondur. 2011; 79(2):85-93. Disponible en: http://www.bvs.hn/RMH/pdf/2011/pdf/Vol79-2-2011-10.pdf
Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015;21 (1):1-87. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25869408
Gonzales N, Rodríguez E, Manrique H. Características clínicas y factores asociados a morbilidad intrahospitalaria en los pacientes con diabetes mellitus tipo 2. Rev Soc Peru Med Interna. 2013; 26(4):159-65. Disponible en: http://medicinainterna.net.pe/pdf/2013/vol26num4/trabajo%20 original2.pdf
Sanal TS, Nair NS, Adhikari P. Factors associated with poor control of type 2 diabetes mellitus : A systematic review and Meta-analysis. J Diabetol. 2011;2(3):4. Disponible en: http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2011;volume=2;issue=3;spage=4;epage=4;aulast=Sanal;type=0
Juarez DT. Factors Associated With Poor Glycemic Control or Wide Glycemic Variability Among Diabetes Patients in Hawaii, 2006–2009. Prev Chronic Dis. 2012;9: 120065. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23017247
Feldman BS, Cohen-Stavi CJ, Leibowitz M, Hoshen MB, Singer SR, Bitterman H, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS One. 2014;9(9): e108145.Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108145
Lopez JMS, Bailey RA, Rupnow MFT, Annunziata K. Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey. Clin Ther. 2014;36(4):494-506. Disponible en: http://www.clinicaltherapeutics.com/article/S0149-2918(14)00013-7/abstract
Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study. BMC Public Health. 2005;5 (1):36. Disponible en: https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-5-36
Verma M., Paneri S., Raman P.G. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian J Clin Biochem. 2006;21(1):142-6. Disponible en: https://link.springer.com/article/10.1007/BF02913083
Group UPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. The Lancet. 1998;352(9131):837-53. Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)07019-6/abstract
Williams Textbook of Endocrinology - 12th Edition [Internet]. [citado 21 de agosto de 2017]. Disponible en: https://www.elsevier.com/books/williams-textbook-of-endocrinology/melmed/978-1-4377-0324-5
Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia Associated with Poor Glycemic Control in Type 2 Diabetes Mellitus and the Protective Effect of Metformin Supplementation. Indian J Clin Biochem. 2012;27(4):363- 9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24082461
Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27(6):1496-504. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15161808
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
